Paroxysmal sympathetic hyperactivity (PSH) has predominantly been described after
traumatic brain injury (TBI), which is associated with hyperthermia, hypertension …

The objective of the Australian Traumatic Brain Injury (AUS-TBI) Initiative is to develop a
data dictionary to inform data collection and facilitate prediction of outcomes of people who …

β-Blockers for traumatic brain injury: A systematic review a... : Journal of Trauma and Acute
Care Surgery β-Blockers for traumatic brain injury: A systematic review and meta-analysis …

Introduction. Most cases of paroxysmal sympathetic hyperactivity (PSH) result from traumatic
brain injury (TBI). Little is known about its pathophysiology and treatment, and several …

Paroxysmal sympathetic hyperactivity (PSH) is a relatively common, but often unrecognized,
complication of acute diffuse or multifocal brain diseases, most frequently encountered in …

Introduction Severe traumatic brain injury (sTBI) is a leading cause of mortality in children.
As clinical prognostication is important in guiding optimal care and decision making, our …

Background Paroxysmal sympathetic hyperactivity (PSH) is a syndrome of excessive
sympathetic activity, mainly occurring in severe traumatic brain injury. However, few studies …

PURPOSE OF REVIEW Autonomic hyperactivity is a relatively common consequence of
severe acute brain injury and can also be seen with spinal cord and peripheral nerve …

Background To explore the clinical characteristics and prognosis of autonomic dysfunction
and paroxysmal sympathetic hyperactivity (PSH), and evaluate the efficacy of drugs used to …

The identification and treatment of paroxysmal sympathetic hyperactivity (PSH) still present a
significant challenge. We assessed the efficacy of pharmacological agents in treating PSH …